In 2025, SGD Pharma continued to turn sustainability into a driver of long-term value creation.

Our approach combines environmental action, workplace safety, responsible procurement and business ethics. These priorities guide our decisions across operations and throughout our value chain.

Here are four examples of how our sustainability initiatives in 2025 translated commitments into concrete actions.

Decarbonization: Modernizing Glass Manufacturing in India

Reducing our environmental impact remains a key priority.

At our Vemula plant in India, we completed a major furnace rebuild using next-generation hybrid technology.

This investment aims to improve energy efficiency and reduce the carbon intensity of glass production.

Moreover, the project modernizes a critical industrial asset while supporting our long-term decarbonization strategy.

The initiative demonstrates how industrial performance and climate action can advance together.

Workplace Safety: Building a Stronger Prevention Culture

Our employees play a central role in our sustainability journey.

Every year, SGD Pharma's Safety Week brings teams together across our manufacturing sites worldwide.

Through workshops, practical activities and experience sharing, employees strengthen their understanding of workplace risks.

These initiatives also encourage everyone to adopt safer behaviors and take an active role in preventing accidents.

For SGD Pharma, safety is a shared responsibility. It supports both employee well-being and operational performance.

Responsible Procurement: Assessing 371 Critical Suppliers

Sustainability extends beyond our manufacturing sites. It also involves the companies we work with.

In 2025, SGD Pharma reassessed 371 critical suppliers using 61 environmental, social and governance (ESG) criteria.

This assessment covered:

  • 90% of purchasing volume
  • 70% of total procurement spend
  • 61 ESG assessment criteria

The results helped us identify opportunities for improvement across our supply chain.

We provided direct support to lower-performing suppliers. Meanwhile, we encouraged suppliers rated Green or Yellow to continue strengthening their sustainability practices.

This structured approach helps integrate responsible procurement into our business relationships.

Business Ethics: Strengthening Compliance and Integrity

Responsible business practices are another essential part of our ESG strategy.

Our global Anti-Corruption Policy applies to all employees and business partners.

In 2025, our action plan covered 100% of high-risk functions.

Key measures included:

  • Annual Ethical Business Conduct certification and conflict-of-interest declarations.
  • Stronger selection and monitoring procedures for agents and distributors.
  • Dedicated procurement procedures for support functions.

These actions help strengthen transparency and reduce ethical risks across our operations.

Furthermore, SGD Pharma reported no ethical disputes or litigation for several years.

Sustainability as a Driver of Long-Term Value

These four initiatives represent only part of SGD Pharma's sustainability efforts in 2025.

From furnace modernization to employee safety, supplier assessments and ethical governance, each action contributes to a more responsible business.

Together, they demonstrate our commitment to integrating sustainability into daily operations and long-term decisions.

For SGD Pharma, sustainability is not just a commitment. It is a driver of resilience, competitiveness and lasting value creation.